The Driscoll Firm Legal Blog Archive

There are two ways that products can receive FDA (U.S. Food & Drug Administration) approval – a “formal” process referred to as the 501(k), which requires clinical testing and studies, and an “informal” process referred to as the 510(k), which allows products that are similar to those already on the market to be “fast tracked” through the process. Transvaginal mesh (TVM) products were subject only to the latter process. Here’s what it means to the thousands of women who suffered… Read More

A new Yaz side effects lawsuit filed by two California women alleges that fourth-generation birth control products, such as Yaz, Yasmin, Ocella and Beyaz, can cause injuries that include Deep Vein Thrombosis (DVT), which can lead to other serious injuries as well. Like thousands of other women who use these drugs, both of these plaintiffs suffered DVT and now worry about how it will affect them in the future. They Should Have Warned Us! That’s what the plaintiffs in the… Read More

Closing arguments have been made in the first Actos bladder cancer lawsuit to go to trial. The plaintiff’s counsel told jurors that Takeda’s internal company e-mails confirm that the Japanese drug maker hid Actos bladder cancer risks from the public in order to increase its profits. The 79-year-old plaintiff, now dying of bladder cancer after taking Actos, is seeking $5.3 million in compensation. Takeda’s Internal E-mails Likely To Be Damaging Takeda continues to deny that its Type 2 diabetes drug,… Read More

Benefactor of Public Justice